193 - 204 of 7279 results

New hypertension guidelines from the American College of Cardiology have lowered the threshold for starting pharmacotherapy in certain groups of patients. IN addition there is a new classification system introduced


71% of adults in the United States are overweight or obese. The impact the medical community is making on reducing high rates of overweight and obesity is less than optimal. Primary care providers (PCPs) bear witness to this staggering statistic on a daily basis and are in a unique position to address this problem. To tackle this problem PCPs must be up to date on best evidence for addressing overweight and obese status in their patients. What seems simple might not be the case. As clinical evidence for best practice in treating overweight and obese patients grows, which approach is considered best. With limited time for patient encounters and higher patient volumes, what health counseling, patient education or behavioral health strategies will work best. With a variety of diets available for patients to choose, which one is preferred. The DIETFITS Randomized Clinical Trial offers direction for nutritional advice in this important and serious public health concern.


A recent research study published in JAMA Internal Medicine examined the use of antibiotics to treat acute sinusitis based upon the Infectious Diseases Society of America (IDSA) guideline recommending 5-7 days when antibiotics are indicated and found that most courses of antibiotics are too long. Listen to this week’s episode to learn more.


Immunization practices are constantly in flux as new vaccines are approved and guidelines are updated. Recently, the FDA approved a 2-dose hepatitis B virus (HBV) vaccine and a new 2-dose herpes zoster (HZ) vaccine. Additionally, the CDC now recommends a 2-dose human papillomavirus (HPV) vaccine schedule, a change from the previous recommendation for a 3-dose schedule. This session will discuss the changing landscape of immunization practices and recent changes to recommendations.


HPV immunization has been recommended for pre-teens and teens for over a decade, however vaccination rates remain low. In October 2016 the CDC changed their recommendations to 2 doses of HPV vaccine in teens before their 15th birthday (from 3 doses), does this make it easier for completion?


In this podcast episode, we will talk about how systolic hypertension affects outcomes, put into context a recent JACC systematic review paper on the topic and JNC 8. We will also discuss the Number Needed to Treat (NNT) and the Number Needed to Harm (NNH).


What are your evidence-based strategies for managing acute, subacute and chronic low back pain? A review of the current American College of Physicians Clinical Practice Guideline can renew your toolkit as you help your patients with back pain maintain a healthy and active lifestyle.


This session will review The Menopause Strategies: Finding Lasting Answers for Symptoms and Health (MsFLASH) series of 4 randomized controlled trials pooling individual data that will provide guidance for clinicians in discussing pharmacologic and non-pharmacologic options for their peri and postmenopausal patients.


In this week's podcast episode, we will identify the known health risks of OSA and outcomes of OSA treatment, discuss the new USPSTF screening recommendations on OSA and consider application of the new recommendations, known risks and outcomes of practice.


In 2013, a groundbreaking clinical trial from Spain touted the benefits of the Mediterranean Diet to reduce CVD risk. A recent review of the study found some irregularities in the randomization procedure that cast concern on the validity of the findings. After reanalysis of the data, however, the results were essentially the same.


Oxygen is frequently given to patients routinely during the initial treatment of a myocardial infarction, but there is a lack of data to support or refute this. A recent systematic review found no benefit in patients who did not have baseline hypoxia. Oxygen therapy continues to be indicated for those with hypoxia and needs to be used with caution in COPD patients with carbon dioxide retention